B. Riley Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,736
Closed -$202K 1289
2022
Q1
$202K Buy
+2,736
New +$190K 0.01% 1214
2019
Q4
Sell
-11,830
Closed -$605K 869
2019
Q3
$605K Buy
11,830
+1,907
+19% +$90.8K 0.06% 340
2019
Q2
$420K Buy
9,923
+3,486
+54% +$151K 0.05% 440
2019
Q1
$319K Buy
+6,437
New +$291K 0.04% 470
2015
Q1
Sell
-53
Closed -$1 1132
2014
Q4
$1 Buy
+53
New +$1.17K ﹤0.01% 3549
2014
Q3
Sell
-100
Closed -$2.39K 1145
2014
Q2
$2.39K Sell
100
-15,681
-99% -$378K ﹤0.01% 2204
2014
Q1
$420K Buy
15,781
+7,147
+83% +$170K 0.13% 180
2013
Q4
$174K Buy
8,634
+4,521
+110% +$83.9K 0.06% 388
2013
Q3
$72K Sell
4,113
-2,795
-40% -$48.4K 0.02% 603
2013
Q2
$116K Buy
+6,908
New +$107K 0.04% 502

Other funds holding GMED

B. Riley Wealth Advisors's GMED Position: Q2 2022 in Review

B. Riley Wealth Advisors sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 2,736 shares — an estimated $202K sold.

B. Riley Wealth Advisors first reported a position in GMED in Q2 2013 and held it in 10 quarters. The position peaked at $605K in Q3 2019. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • B. Riley Wealth Advisors reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 2,736 Globus Medical shares in Q2 2022, an estimated $202K.
  • B. Riley Wealth Advisors first reported a position in Globus Medical in Q2 2013 and held it in 10 quarters.
  • B. Riley Wealth Advisors's Globus Medical position peaked at $605K in Q3 2019.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.